ESMO-Advanced-Courses-KRAS-Targeting-NSCLC-2022-1000x250-november

Start date: 28 Nov 2022
End date: 29 Nov 2022
Location: Virtual, GMT +8

Please kindly note that the virtual course programme timings are to be considered GMT+8 (Singapore Local Time)

Learning Objectives

Understanding the function and biology of KRAS in normal and malignant cells
Gaining insights in the spectrum of KRAS molecular aberrations, platforms and strategies for molecular testing
In depth discussion of emerging therapeutic strategies and clinical research in KRAS mutated NSCLC
Presenting novel data on biomarkers of benefit, mechanisms of resistance and combinatorial therapeutic strategies of KRAS G12C inhibition and beyond

Download the programme

How to apply

Application is via online form. During the application process you will be required to upload the following:

Your CV including a list of your publications

Application deadline

Application deadline has now closed.

Who can apply?

While this online course is primarily aimed at experienced oncologists resident in Asia, application is open to all ESMO members.

To apply, ESMO membership is mandatory. If you are not an ESMO member, or need to renew your membership, please visit the ESMO membership pages.

What's included?

Successful applicants will benefit from complimentary registration for this virtual course.

Accreditation

The programme of this virtual event has been accredited with 6 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.

Co-Chairs:

Myung-Ju Ahn, Republic of Korea
Federica Di Nicolantonio, Italy